Live Well with Michelle

Two numbers that may reveal more about your future health than almost anything else? In "Ask a Cardiologist", Michelle finds out more about the "silent killer" damaging the heart, brain and kidneys long before symptoms appear. This episode explores what your blood pressure is really telling you, the everyday habits that make the biggest difference, and the latest advances in treatment for people whose hypertension remains difficult to control. Hosted by Michelle Martin with Dr. Chin Chee Tang, Senior Consultant Cardiologist at the National Heart Centre Singapore.

After months of AI-fuelled gains, investors hit the brakes on semiconductor stocks, sending SanDisk, Micron, Western Digital, Marvell Technology and Oracle sharply lower this week as concerns grew over lofty valuations and massive AI spending. Yet money didn't leave tech entirely - it rotated into profitable software names. Which names have gained ground? We unpack what this shift says about the next phase of the AI boom, why JPMorgan Chase's strong earnings are reassuring investors about the health of the US economy, and what IBM's disappointing outlook reveals about rising expectations for AI. We also examine whether softer US inflation could give the Federal Reserve more room to cut rates, and why geopolitics may matter more than inflation in the days ahead. Plus, the stocks and sectors investors should keep firmly on their watchlist. Hosted by Michelle Martin.

We have 3 small cap Singapore ideas to dissect and also take on Trump's U-turn on a proposed Hormuz shipping toll to the next phase of the AI boom. We separate signal from noise in a market driven by geopolitics, earnings and investor psychology, looking at Wall Street's earnings season and what South Korea's sharp market sell-off teaches. The heart of the discussion with Swapnil Mishra, Author of "Investing for the Clueless, Reckless and Overly Cautious"  unpacks what could be the next major investment opportunity, after NVIDIA. Hosted by Michelle Martin.

AI's biggest chipmaker is smashing records - but oil prices, legal battles and geopolitical tensions are testing investor confidence. Hosted by Michelle Martin, we unpack TSMC's blockbuster revenue growth ahead of earnings, the latest Middle East tensions pushing oil prices higher, and Apple's legal clash with OpenAI over its hardware ambitions. We also ask whether DBS deserves its S$200 billion valuation, examine the legal challenge to the Paramount-Warner Bros. Discovery merger, and look at Lum Chang Creations' move to the SGX Mainboard.

Heart disease is the leading cause of death in women - yet many don't realise menopause marks a critical turning point for cardiovascular health. Hosted by Michelle Martin, Dr Pinakin V. Parekh explains how hormonal changes during menopause can increase risk of a heart attack. We also discuss hormone therapy, prevention and why women need a more integrated approach to midlife healthcare.

Debt can build wealth - or quietly destroy it. So where's the line? Hosted by Michelle Martin, Christopher Tan, CEO of Providend, explores whether attitudes towards borrowing are changing among younger Singaporeans. From mortgages and credit cards to investment leverage and premium financing for insurance, we examine when debt is a powerful financial tool - and when it becomes a dangerous trap. Plus, what are the financial and psychological guardrails that can help borrowers avoid costly mistakes?

Hosted by Michelle Martin, this episode previews a pivotal week for investors as earnings season kicks off with JPMorgan Chase and Netflix, while fresh inflation data and renewed U.S.-Iran tensions add another layer of uncertainty. We unpack Bank of America's top earnings picks, ask whether AI momentum can continue after standout performances from SK Hynix and Meta.

Michelle speaks with the first Gastroenterologist in Singapore to be recognised as a National Fellow by World Obesity Federation, to find out about advances in weight control. As science transforms our understanding of obesity, experts now recognise it as a chronic disease shaped by biology, hormones and the brain - not just lifestyle choices. Hosted by Michelle Martin in conversation with Dr Ravishankar Asok-kumar, Senior Consultant, Gastroenterologist and Advanced Therapeutic Endoscopist at Singapore General Hospital, this episode explores why weight regain is so common, where GLP-1 medications and new minimally invasive treatments fit, and why personalised obesity care could change not just our weight, but our long-term health, confidence and quality of life. 

Should you buy a REIT before it recovers? How can you tell if a REIT is on the path of recovery? Michelle finds out in this discussion as more investors ask if Singapore's beaten-down property trusts are finally turning the corner, or if the rebound is only temporary. After years of higher interest rates and weaker distributions, investors are looking for signs of a sustained recovery. Hosted by Michelle Martin, this episode examines three REITs to watch: Mapletree Logistics Trust, Mapletree Pan Asia Commercial Trust and Frasers Centrepoint Trust. We explore what their upcoming results could reveal about logistics demand, retail resilience, asset recycling, financing costs and the transformative potential of the Johor Bahru–Singapore RTS Link. If you're hunting for income, this conversation highlights the metrics that matter most before making your next investment decision.

In this episode, hosted by Michelle Martin, we unpack SK Hynix's record-breaking US$26.5 billion U.S. listing and why investors are pouring money into the critical infrastructure powering artificial intelligence. We explore Meta's move into AI coding, OpenAI's launch of its long-awaited AI "super app," and the growing legal battle over whether AI companies should compensate news publishers for the content that trains their models. We also check in on a steadier Wall Street as geopolitical tensions ease and examine what calmer markets mean for investors. Finally, we look at why the next stage of the AI revolution may be won not just by software developers- but by the companies building the chips, memory and infrastructure behind it.